An In-depth Look at the Past and Future of Antibody Drug Discovery and Development
In this white paper, we celebrate the progress antibody therapeutics have made over the last 3 decades. We also look to the future for how the next generation of antibodies will continue to provide new approaches to treating and curing chronic, genetic, and infectious diseases.
You will learn:
- How and why antibodies became a major therapeutic modality
- Which applications continue to have clinical success in the development of antibody therapeutics
- Emerging trends in the clinical pipelines of antibody therapeutics and which therapeutic applications could create the next blockbuster antibody drug
- How antibodies contribute to a number of other advanced therapeutics
- Challenges in the discovery and development of antibody therapeutics, along with potential solutions
This white paper is an essential read for any company looking to build a biologics pipeline and seeking a deeper understanding of this advanced modality and how it continues to transform the industry.